平潭海洋公司 PME 深 沪
等待开盘 11-07 09:30:00 美东时间
0.27
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.27
- 总市值 2320.41万
- 52周最高 1.12
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.0001
- 委 比 0.00%
- 总股本 8594.10万
- 历史最高 12.35
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0001
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ovid Therapeutics Reports Results for New Epilepsy Drug in Early Human Trial
Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced positive topline results from its Phase
10-03 19:03
Pro Medicus Unaffected by US Pharmaceutical Tariffs
An update from Pro Medicus Limited ( ($AU:PME) ) is now available. Pro Medicus ...
09-29 09:08
科力远携手印尼BBK深耕换电业务，构建东南亚小动力电池全产业链生态
在印尼，摩托车是民众出行的绝对主力，但超1.3亿辆燃油摩托车带来的环境问题日益严峻。为此，印尼政府近年密集出台“油改电”政策，明确到2025年将20%燃油二轮车...
09-24 09:41
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
Extensive strategic, financial and operational overhaul has reshaped and refocused our business; Strong progress on multiple fronts Commercial and R&D Highlights: Recruitment initiated in th...
09-05 19:00
道不同不相为谋！欧洲退休金巨头从贝莱德撤资140亿欧元
①因不契合可持续性投资理念，荷兰退休基金PFZW于周三宣布从贝莱德（BlackRock）撤资140亿欧元； ②美国ESG风潮在特朗普上任后大幅降温，多家欧洲公司因意见不合与美国资管公司分道扬镳。
09-04 17:03
Pro Medicus Director Increases Shareholding
Pro Medicus Limited ( ($AU:PME) ) has shared an update. Pro Medicus Limited ann...
09-03 07:07
Pro Medicus Secures ATO for CloudPACS with U.S. Veterans’ Affairs
The latest announcement is out from Pro Medicus Limited ( ($AU:PME) ). Pro Medi...
09-01 10:37
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
Profound Medical Corp. will participate in the Lake Street Capital Markets “BIG9” Conference on September 11, 2025, in New York City, focusing on investor meetings. The company commercializes TULSA-PRO®, an incision-free prostate treatment using real-time MRI, AI, and ultrasound, and Sonalleve®, for uterine fibroids and bone metastases. Both products are CE marked and approved by regulatory bodies, with TULSA-PRO® also FDA cleared.
08-28 12:00
Senstar Technologies Corporation Reports Second Quarter 2025 Financial Results
OTTAWA, ON, Aug. 25, 2025 /PRNewswire/ -- Senstar Technologies Corporation (NASDAQ: SNT), a leading international provider of comprehensive physical, video and access control security produc...
08-26 04:10
Deere Reports Third Quarter Net Income of $1.289 Billion
Disciplined execution yields solid results in the face of a challenging environment. Customers remain cautious amid ongoing uncertainty. Full-year net income guidance narrowed. MOLINE, Ill.,...
08-14 18:27
